SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-000674
Filing Date
2021-08-03
Accepted
2021-08-03 10:01:20
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-20210630.htm   iXBRL 10-Q 2721486
2 EX-10.2 mcrb-20210630ex10_2.htm EX-10.2 175253
3 EX-10.3 mcrb-20210630ex10_3.htm EX-10.3 24897
4 EX-31.1 mcrb-20210630ex31_1.htm EX-31.1 14457
5 EX-31.2 mcrb-20210630ex31_2.htm EX-31.2 14374
6 EX-32.1 mcrb-20210630ex32_1.htm EX-32.1 8240
7 EX-32.2 mcrb-20210630ex32_2.htm EX-32.2 8629
  Complete submission text file 0000950170-21-000674.txt   8822547

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20210630_def.xml EX-101.DEF 159796
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mcrb-20210630_cal.xml EX-101.CAL 46126
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20210630.xsd EX-101.SCH 52880
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20210630_pre.xml EX-101.PRE 308560
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20210630_lab.xml EX-101.LAB 430823
13 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20210630_htm.xml XML 1535450
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 211138308
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences